Current periprocedural management of ablation for atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.

@article{Chen2014CurrentPM,
  title={Current periprocedural management of ablation for atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.},
  author={Jian Chen and Derick Todd and M{\'e}l{\`e}ze Hocini and Torben Bjerregaard Larsen and Maria Grazia Bongiorni and Carina Blomstr{\"o}m-Lundqvist},
  journal={Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology},
  year={2014},
  volume={16 3},
  pages={
          378-81
        }
}
  • Jian Chen, D. Todd, +3 authors C. Blomström-Lundqvist
  • Published 1 March 2014
  • Medicine
  • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
The purpose of this EP Wire survey was to assess clinical practice in periprocedural management of atrial fibrillation ablation. This survey is based on an electronic questionnaire sent to the European Heart Rhythm Association Research Network members. Responses were received from 78 centres in 20 countries. The results of the survey have shown that periprocedural management is generally in accordance with guidelines and consensus recommendations on ablation for atrial fibrillation ablation… 
View on PubMed
academic.oup.com
20 Citations
Background Citations
3
Results Citations
2

20 Citations

Citation Type

Citation Type

Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association survey.
TLDR
The results of the survey have shown that management of cardiac arrhythmias is generally in accordance with the guidelines and consensus recommendations on management, although there are some areas of variation, especially on age limit and exclusion of elderly patients for anticoagulation, ablation, and device therapy.
[Pericardioversion and catheter ablation use of rivaroxaban in light of X-VERT and VENTURE-AF trials].
  • R. Akıllı, M. Demir
  • Medicine
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
  • 2017
TLDR
The efficacy and safety parameters of continuous rivaroxaban treatmentn compared with dose-adjusted vitamin K antagonist therapy in patients who were planned to undergo cardioversion and catheter ablation according to the data of X-VERT and VENTUREAF trials are discussed.
Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
  • T. Potpara, T. Larsen, +7 authors C. Blomström-Lundqvist
  • Medicine
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2015
TLDR
The results show the increasing use of NOAC in patients undergoing AF ablation and emphasize the need for more information to guide the periprocedural use of both NOACs and VKAs in real-world setting.
Catheter ablation for atrial fibrillation: results from the first European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA) Part II.
  • Jian Chen, N. Dagres, +7 authors C. Blomström-Lundqvist
  • Medicine
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2015
TLDR
The centre volume played an important role in patient selection, strategy choice, and had impact on the rate of periprocedural complication, and in conclusion, PVI was still the main strategy for AF ablation.
Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians
TLDR
Future research should enable the creation of more durable ablative lesions and the selection of the optimal lesion set in each patient according to the degree of atrial remodeling to provide better long-term CA success and expand indications for the procedure, especially among the patients with non-paroxysmal AF.
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS).
  • C. Sticherling, F. Marín, +12 authors G. Lip
  • Medicine
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2015
TLDR
The present document covers the antithrombotic management during different ablation procedures, implantation or exchange of cardiac implantable electronical devices (CIEDs), as well as the management of peri-interventional bleeding complications.
Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study.
Management and Outcome of Periprocedural Cardiac Perforation and Tamponade with Radiofrequency Catheter Ablation of Cardiac Arrhythmias: A Single Medium-Volume Center Experience
TLDR
The outcome of CT was mostly favorable after pericardiocentesis, but readily accessible cardiothoracic surgery back-up should be mandatory in RFA centers.
Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter.
TLDR
Improved understanding of risk factors for post-ablation HF may be critical in developing strategies to address during AF ablation.
Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
TLDR
In patients undergoing CA for AF, the use of uninterrupted oral rivaroxaban was feasible and event rates were similar to those for uninterrupted VKA therapy, as well as in patients undergoing catheter ablation for AF.
...
1
2
...

References

SHOWING 1-10 OF 14 REFERENCES
Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation.
TLDR
Variation in clinical practice is shown, but reassuringly some consistency with guidelines and consensus recommendations on the management of periprocedure ( devices, ablation) antithrombotic therapy is found.
Atrial fibrillation ablation techniques.
TLDR
The focus of this questionnaire is on the ablation strategy, such as the use of different lesion sets or sites of ablation in the various forms of AF, and on the technical aspects of catheter ablation with respect to energy sources and imaging modalities.
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
  • H. Calkins, K. Kuck, +43 authors D. Wilber
  • Medicine
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2012
TLDR
This 2012 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a Task Force, convened by the Heart Rhythm Society, the European Heart Rhythm Association, and the European Cardiac Arrhythmia Society and charged with defining the indications, techniques, and outcomes of this procedure.
Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography.
  • B. Aldhoon, D. Wichterle, P. Peichl, R. Cihak, J. Kautzner
  • Medicine
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2013
TLDR
Atrial fibrillation ablation procedures guided by ICE in a high-volume centre are associated with low rate of serious complications and the composite risk score consisting of body weight, age, gender, and complexity of procedure predicted complications.
Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature.
  • S. Hohnloser, A. Camm
  • Medicine
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2013
TLDR
Dabigatran has similar efficacy and safety compared with warfarin when used for periprocedural anticoagulation during AF ablation, as well as similar rates of minor bleeding events between the two treatment groups.
Complications of Atrial Fibrillation Ablation in a High‐Volume Center in 1,000 Procedures: Still Cause for Concern?
Introduction: Catheter ablation is potentially curative treatment for atrial fibrillation (AF). However, complications are more frequent and more severe compared with other ablation procedures. We…
In-Hospital Complications Associated With Catheter Ablation of Atrial Fibrillation in the United States Between 2000 and 2010: Analysis of 93 801 Procedures
TLDR
There was a significant association between operator and hospital volume and adverse outcomes and a need for future research into identifying the safety measures in AF ablations and instituting appropriate interventions to improve overall AF ablation outcomes.
Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications.
TLDR
A clear discrepancy between recommendations in guidelines and actual practice in patients with atrial fibrillation is revealed and a significant under use of thromboembolic prophylaxis in patients at high risk for such events is found.
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
  • A. Camm, P. Kirchhof, +22 authors F. Rutten
  • Medicine
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2010
Guidelines summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategy for an individual patient…
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.
TLDR
A prospective, randomized, double blind, Active-controlled, superiority study of Vernakalant vs. amiodarone in Recent Onset atrial fibrillation for the prevention of cardiovascular Hospitalization or death from any cause.
...
1
2
...